{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T23:00:02Z","timestamp":1784415602351,"version":"3.55.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2016,8,4]],"date-time":"2016-08-04T00:00:00Z","timestamp":1470268800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s10875-016-0324-z","type":"journal-article","created":{"date-parts":[[2016,8,4]],"date-time":"2016-08-04T07:43:59Z","timestamp":1470296639000},"page":"667-676","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Lymphoma Secondary to Congenital and Acquired Immunodeficiency Syndromes at a Turkish Pediatric Oncology Center"],"prefix":"10.1007","volume":"36","author":[{"given":"Hikmet G.","family":"Tanyildiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Handan","family":"Dincaslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulsan","family":"Yavuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emel","family":"Unal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aydan","family":"Ikinciogullar\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Figen","family":"Dogu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurdan","family":"Tacyildiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,4]]},"reference":[{"key":"324_CR1","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00043426-198722000-00017","volume":"9","author":"AH Filipovich","year":"1987","unstructured":"Filipovich AH, Heinitz KJ, Robison LL, Frizzera G. The immunodeficiency cancer registry. A research resource. Am J Pediatr Hematol Oncol. 1987;9:183\u20134.","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"324_CR2","first-page":"35","volume":"14","author":"KS Elenitoba-Johnson","year":"1997","unstructured":"Elenitoba-Johnson KS, Jaffe ES. Lymphoproliferative disorders associated with congenital immunodeficiencies. Semin Diagn Pathol. 1997;14:35\u201347.","journal-title":"Semin Diagn Pathol"},{"key":"324_CR3","first-page":"91","volume":"5","author":"AH Filipovich","year":"1994","unstructured":"Filipovich AH, Mathur A, Kamat D, Kersey JH, Shapiro RS. Lymphoproliferative disorders and other tumors complicating immunodeficiency. Immunodeficiency. 1994;5:91\u2013112.","journal-title":"Immunodeficiency"},{"key":"324_CR4","first-page":"89","volume":"77","author":"D Morrell","year":"1986","unstructured":"Morrell D, Cromartie E, Swift M. Mortality and cancer incidence in 236 patients with ataxia telangiectasia. J Natl Cancer Inst. 1986;77:89\u201392.","journal-title":"J Natl Cancer Inst"},{"key":"324_CR5","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/BF00915550","volume":"7","author":"C Cunningham-Rundles","year":"1987","unstructured":"Cunningham-Rundles C, Siegal FP, Cunningham-Rundles S, Lieberman P. Incidence of cancer in 98 patients with common variable immunodeficiency. J Clin Immunol. 1987;7:294\u2013301.","journal-title":"J Clin Immunol"},{"key":"324_CR6","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1182\/blood.V87.2.423.bloodjournal872423","volume":"87","author":"AMR Taylor","year":"1996","unstructured":"Taylor AMR, Metcalfe JA, Thick J, Mak YF. Leukemia and lymphoma in ataxia telangiectasia. Blood. 1996;87:423\u201338.","journal-title":"Blood"},{"key":"324_CR7","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1136\/pgmj.2009.080630","volume":"85","author":"SE Turvey","year":"2009","unstructured":"Turvey SE, Bonilla FA, Junker AK. Primary immunodeficiency diseases: a practical guide for clinicians. Postgrad Med J. 2009;85:660\u20136.","journal-title":"Postgrad Med J"},{"key":"324_CR8","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.blre.2008.03.009","volume":"22","author":"H Tran","year":"2008","unstructured":"Tran H, Nourse J, Hall S, Green M, Griffiths L, Gandhi MK. Immunodeficiency-associated lymphomas. Blood Rev. 2008;22:261\u201381.","journal-title":"Blood Rev"},{"key":"324_CR9","doi-asserted-by":"crossref","unstructured":"Meyn MS. Chromosome instability syndromes: lessons for carcinogenesis. In Kaston MB, editor. Genetic instability and tumorigenesis. Current topics in microbiology and immunology; 1997. pp. 71\u2013148.","DOI":"10.1007\/978-3-642-60505-5_6"},{"key":"324_CR10","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1136\/adc.73.5.431","volume":"73","author":"AJ Green","year":"1995","unstructured":"Green AJ, Yates JR, Taylor AM, Biggs P, McGuire GM, McConville CM, et al. Severe microcephaly with normal intellectual development: the Nijmegen breakage syndrome. Arch Dis Child. 1995;73:431\u20134.","journal-title":"Arch Dis Child"},{"key":"324_CR11","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1002\/1097-0142(19940301)73:5<1522::AID-CNCR2820730533>3.0.CO;2-T","volume":"73","author":"U Overberg-Schmidt","year":"1994","unstructured":"Overberg-Schmidt U, Wegner RD, Baumgarten E, G\u00fcnther A, Ebell W, Stein H, et al. Low-grade non-Hodgkin\u2019s lymphoma after high-grade non-Hodgkin\u2019s lymphoma in a child with ataxia telangiectasia. Cancer. 1994;73:1522\u20135.","journal-title":"Cancer"},{"key":"324_CR12","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/MPH.0b013e31814d67f4","volume":"29","author":"D Janic","year":"2007","unstructured":"Janic D, Dokmanovic L, Jovanovic N, Lazic J. T-cell acute lymphoblastic leukemia in a child with ataxia-telangiectasia: case report. J Pediatr Hematol Oncol. 2007;29:713\u20135.","journal-title":"J Pediatr Hematol Oncol"},{"key":"324_CR13","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1080\/08880010802106614","volume":"5","author":"LM Sharma","year":"2008","unstructured":"Sharma LM, Kashyap R, Gupta S, Bhargava M. B-cell acute lymphoblastic leukemia in a child with ataxia-telangiectasia. Pediatr Hematol Oncol. 2008;5:473\u20136.","journal-title":"Pediatr Hematol Oncol"},{"key":"324_CR14","doi-asserted-by":"crossref","unstructured":"Kastan MB. DNA damage responses: mechanisms and roles in human disease: 2007 G.H.A Clowes Memorial Award Lecture. Mol Cancer Res. 2008;6:517\u201324.","DOI":"10.1158\/1541-7786.MCR-08-0020"},{"key":"324_CR15","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00043426-198722000-00018","volume":"9","author":"F Hecht","year":"1987","unstructured":"Hecht F, Hecht BK. Chromosome changes connect immunodeficiency and cancer in ataxia-telangiectasia. Am J Pediatr Hematol Oncol. 1987;9:185\u20138.","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"324_CR16","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1023\/A:1008391923792","volume":"11","author":"K Seidemann","year":"2000","unstructured":"Seidemann K, Henze G, Beck JD, Sauerbrey A, K\u00fchl J, Mann G, et al. Non-Hodgkin\u2019s lymphoma in pediatric patients with chromosomal breakage syndromes (AT and NBS): experience from the BFM trials. Ann Oncol. 2000;11:141\u20135.","journal-title":"Ann Oncol"},{"key":"324_CR17","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1158\/1541-7786.MCR-07-0058","volume":"5","author":"KH Maclean","year":"2007","unstructured":"Maclean KH, Kastan MB, Cleveland JL. Atm deficiency affects both apoptosis and proliferation to augment Myc-induced lymphomagenesis. Mol Cancer Res. 2007;5:705\u201311.","journal-title":"Mol Cancer Res"},{"key":"324_CR18","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/0140-6736(92)91769-5","volume":"340","author":"JPH Shield","year":"1992","unstructured":"Shield JPH, Strobel S, Levinsky RJ, Morgan G. Immunodeficiency presenting as hypergammaglobulinemia with IgG2 subclass deficiency. Lancet. 1992;340:448\u201351.","journal-title":"Lancet"},{"key":"324_CR19","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0031-3955(16)38803-4","volume":"41","author":"RH Buckley","year":"1994","unstructured":"Buckley RH. Breakthroughs in the understanding and therapy of primary immunodeficiency. Pediatr Clin North Am. 1994;41:665\u201390.","journal-title":"Pediatr Clin North Am"},{"key":"324_CR20","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1203\/00006450-199510000-00001","volume":"38","author":"TA Seemayer","year":"1995","unstructured":"Seemayer TA, Gross TG, Egeler RM, Pirruccello SJ, Davis JR, Kelly CM, et al. X-linked lymphoproliferative disease: twenty-five years after the discovery. Pediatr Res. 1995;38:471\u20138.","journal-title":"Pediatr Res"},{"key":"324_CR21","first-page":"3118","volume":"96","author":"J Sumegi","year":"2000","unstructured":"Sumegi J, Huang D, Lanyi A, Davis JD, Seemayer TA, Maeda A, et al. Correlation of mutations of the SH2D1A gene and Epstein-Barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease. Blood. 2000;96:3118\u201325.","journal-title":"Blood"},{"key":"324_CR22","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/(SICI)1096-911X(199912)33:6<536::AID-MPO3>3.0.CO;2-Z","volume":"33","author":"K Seidemann","year":"1999","unstructured":"Seidemann K, Tiemann M, Henze G, Sauerbrey A, M\u00fcller S, Reiter A. Therapy for non-Hodgkin lymphoma in children with primary immunodeficiency: analysis of 19 patients from the BFM trials. Med Pediatr Oncol. 1999;33:536\u201344.","journal-title":"Med Pediatr Oncol"},{"key":"324_CR23","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/(SICI)1096-911X(199812)31:6<491::AID-MPO5>3.0.CO;2-B","volume":"31","author":"C Sandoval","year":"1998","unstructured":"Sandoval C, Swift M. Treatment of lymphoid malignancies in patients with ataxia telangiectasia. Med Pediatr Oncol. 1998;31:491\u20137.","journal-title":"Med Pediatr Oncol"},{"key":"324_CR24","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/pbc.21808","volume":"52","author":"S Shabbat","year":"2009","unstructured":"Shabbat S, Aharoni J, Sarid L, Ben-Harush M, Kapelushnik J. Rituximab as monotherapy and in addition to reduced CHOP in children with primary immunodeficiency and non-Hodgkin lymphoma. Pediatr Blood Cancer. 2009;52:664\u20136.","journal-title":"Pediatr Blood Cancer"},{"key":"324_CR25","first-page":"1860","volume":"31","author":"PP Carbone","year":"1971","unstructured":"Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M. Report of the committee on Hodgkin\u2019s disease staging classification. Cancer Res. 1971;31:1860\u20131.","journal-title":"Cancer Res"},{"key":"324_CR26","first-page":"332","volume":"7","author":"SB Murphy","year":"1980","unstructured":"Murphy SB. Classification, staging and results of treatment of childhood non-Hodgkin\u2019s lymphomas: dissimilarities from lymphomas in adults. Semin Oncol. 1980;7:332\u20139.","journal-title":"Semin Oncol"},{"key":"324_CR27","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa011795","volume":"346","author":"B Coiffier","year":"2002","unstructured":"Coiffier B, Lepage E, Briere J, Herbrecht R, Tilly H, Bouabdallah R, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med. 2002;346:235\u201342.","journal-title":"N Engl J Med"},{"key":"324_CR28","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/pbc.20548","volume":"46","author":"G Kropshofer","year":"2006","unstructured":"Kropshofer G, Wehl G, Klein-Franke A, Herbrecht R, Tilly H, Bouabdallah R, et al. B-cell lymphoma in a girl with ataxia telangiectasia (A-T) treated with rituximab monotherapy. Pediatr Blood Cancer. 2006;46:528\u20139.","journal-title":"Pediatr Blood Cancer"},{"key":"324_CR29","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1046\/j.1365-2141.2003.04041_4.x","volume":"120","author":"G Rossi","year":"2003","unstructured":"Rossi G, Zecca M, Marchi A, de Stefano P, Sammarchi L, Locatelli F. Modified CHOP-chemotherapy plus rituximab for diffuse large B-cell lymphoma complicating ataxia-telangiectasia. Br J Haematol. 2003;120:369\u201371.","journal-title":"Br J Haematol"},{"key":"324_CR30","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/pbc.24696","volume":"61","author":"JT Sandlund","year":"2014","unstructured":"Sandlund JT, Hudson MM, Kennedy W, Onciu M, Kastan MB. Pilot study of modified LMB-based therapy for children with ataxia-telangiectasia and advanced stage high grade mature B-cell malignancies. Pediatr Blood Cancer. 2014;61:360\u20132.","journal-title":"Pediatr Blood Cancer"},{"key":"324_CR31","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0022-3476(80)80133-8","volume":"97","author":"GS Perry III","year":"1980","unstructured":"Perry III GS, Spector BD, Schuman LM, Mandel JS, Anderson VE, McHugh RB, et al. The Wiskott-Aldrich syndrome in the United States and Canada (1892\u20131979). J Pediatr. 1980;97:72\u20138.","journal-title":"J Pediatr"},{"key":"324_CR32","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/0092-8674(94)90528-2","volume":"78","author":"JM Derry","year":"1994","unstructured":"Derry JM, Ochs HD, Francke U. Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell. 1994;78:635\u201344.","journal-title":"Cell"},{"key":"324_CR33","doi-asserted-by":"crossref","first-page":"6288","DOI":"10.1182\/blood-2008-12-115253","volume":"113","author":"M Bosticardo","year":"2009","unstructured":"Bosticardo M, Marangoni F, Aiuti A, Villa A, Grazia RM. Recent advances in understanding the pathophysiology of Wiskott-Aldrich syndrome. Blood. 2009;113:6288\u201395.","journal-title":"Blood"},{"key":"324_CR34","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s00109-009-0467-y","volume":"87","author":"E Staub","year":"2009","unstructured":"Staub E, Groene J, Heinze M, Mennerich D, Roepcke S, Klaman I, et al. An expression module of WIPF1-coexpressed genes identifies patients with favorable prognosis in three tumor types. J Mol Med. 2009;87:633\u201344.","journal-title":"J Mol Med"},{"key":"324_CR35","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2350\/10-01-0787-CR.1","volume":"14","author":"S Du","year":"2011","unstructured":"Du S, Scuderi R, Malicki DM, Willert J, Bastian J, Weidner N. Hodgkin\u2019s and non-Hodgkin\u2019s lymphomas occurring in two brothers with Wiskott-Aldrich syndrome and review of the literature. Pediatr Dev Pathol. 2011;14:64\u201370.","journal-title":"Pediatr Dev Pathol"},{"key":"324_CR36","first-page":"48","volume":"28","author":"S Pasic","year":"2006","unstructured":"Pasic S, Vujic D, Djuricic S, Jevtic D, Grujic B. Burkitt lymphoma-induced ileocolic intussusceptions in Wiskott-Aldrich syndrome. J Pediatr Hematol Oncol. 2006;28:48\u201350.","journal-title":"J Pediatr Hematol Oncol"},{"key":"324_CR37","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/BF00915550","volume":"7","author":"C Cunningham-Rundles","year":"1987","unstructured":"Cunningham-Rundles C, Siegal FP, Cunningham-Rundles S, Lieberman P. Incidence of cancer in 98 patients with common varied immunodeficiency. J Clin Immunol. 1987;7:294\u20139.","journal-title":"J Clin Immunol"},{"key":"324_CR38","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3109\/08880018.2013.792893","volume":"30","author":"S Emir","year":"2013","unstructured":"Emir S, Vezir E, Azkur D, Demir HA, Metin A. Characteristics of children with non-Hodgkin lymphoma associated with primary immune deficiency diseases: descriptions of five patients. Pediatr Hematol Oncol. 2013;30:544\u201353.","journal-title":"Pediatr Hematol Oncol"},{"key":"324_CR39","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1126\/science.7539157","volume":"268","author":"F Riex-Laucat","year":"1995","unstructured":"Riex-Laucat F, Le Deist F, Hivroz C, Roberts IA, Debatin KM, Fischer A, et al. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science. 1995;268:1347\u20139.","journal-title":"Science"},{"key":"324_CR40","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2174\/1381612033392107","volume":"9","author":"JJ Bleesing","year":"2003","unstructured":"Bleesing JJ. Autoimmune lymphoproliferative syndrome (ALPS). Curr Pharm Des. 2003;9:265\u201378.","journal-title":"Curr Pharm Des"},{"key":"324_CR41","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa041432","volume":"351","author":"R Clementi","year":"2004","unstructured":"Clementi R, Dagna L, Dianzani U, Dupr\u00e9 L, Dianzani I, Ponzoni M, et al. Inherited perforin and Fas mutations in a patient with autoimmune lymphoproliferative syndrome and lymphoma. N Engl J Med. 2004;351:1419\u201324.","journal-title":"N Engl J Med"},{"key":"324_CR42","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1080\/10428190310001593166","volume":"45","author":"S Poppema","year":"2004","unstructured":"Poppema S, Maggio E, van den Berg A. Development of lymphoma in autoimmune lymphoproliferative syndrome (ALPS) and its relationship to Fas gene mutations. Leuk Lymphoma. 2004;45:423\u201331.","journal-title":"Leuk Lymphoma"},{"key":"324_CR43","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/10245330500329094","volume":"11","author":"VK Rao","year":"2006","unstructured":"Rao VK, Straus SE. Causes and consequences of the autoimmune lymphoproliferative syndrome. Hematology. 2006;11:15\u201323.","journal-title":"Hematology"},{"key":"324_CR44","first-page":"8","volume":"14","author":"NL Harris","year":"1997","unstructured":"Harris NL, Ferry JA, Swerdlow SH. Posttransplant lymphoproliferative disorders: summary of Society for Hematopathology Workshop. Semin Diagn Pathol. 1997;14:8\u201314.","journal-title":"Semin Diagn Pathol"},{"key":"324_CR45","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1200\/JCO.2003.05.108","volume":"21","author":"KS Baker","year":"2003","unstructured":"Baker KS, DeFor TE, Burns LJ, Ramsay NK, Neglia JP, Robison LL. New malignancies after blood or marrow stem-cell transplantation in children and adults: incidence and risk factors. J Clin Oncol. 2003;21:1352\u20138.","journal-title":"J Clin Oncol"},{"key":"324_CR46","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/sj.bmt.1701554","volume":"23","author":"TG Gross","year":"1999","unstructured":"Gross TG, Steinbuch M, DeFor T, Shapiro RS, McGlave P, Ramsay NK, et al. B-cell lymphoproliferative disorders following hematopoietic stem cell transplantation: risk factors, treatment and outcome. Bone Marrow Transpl. 1999;23:251\u20138.","journal-title":"Bone Marrow Transpl"},{"key":"324_CR47","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1182\/blood.V87.9.3633.bloodjournal8793633","volume":"87","author":"S Bhatia","year":"1996","unstructured":"Bhatia S, Ramsay NK, Steinbuch M, Dusenbery KE, Shapiro RS, Weisdorf DJ, et al. Malignant neoplasms following bone marrow transplantation. Blood. 1996;87:3633\u20139.","journal-title":"Blood"},{"key":"324_CR48","first-page":"2208","volume":"94","author":"RE Curtis","year":"1999","unstructured":"Curtis RE, Travis LB, Rowlings PA, Soci\u00e9 G, Kingma DW, Banks PM, et al. Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood. 1999;94:2208\u201316.","journal-title":"Blood"},{"key":"324_CR49","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1200\/JCO.2000.18.2.348","volume":"18","author":"G Socie","year":"2000","unstructured":"Socie G, Curtis RE, Deeg HJ, Sobocinski KA, Filipovich AH, Travis LB, et al. New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia. J Clin Oncol. 2000;18:348\u201357.","journal-title":"J Clin Oncol"},{"key":"324_CR50","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/00043426-198722000-00019","volume":"9","author":"LL Robison","year":"1987","unstructured":"Robison LL, Stoker V, Frizzera G, Heinitz K, Meadows AT, Filipovich AH. Hodgkin\u2019s disease in pediatric patients with naturally occurring immunodeficiency. Am J Pediatr Hematol Oncol. 1987;9:189\u201392.","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"324_CR51","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1200\/JCO.1987.5.7.1041","volume":"5","author":"MJ Crnkovich","year":"1987","unstructured":"Crnkovich MJ, Leopold K, Hoppe RT, Mauch PM. Stage I to IIB Hodgkin\u2019s disease: the combined experience at Stanford University and the Joint Center for Radiation Therapy. J Clin Oncol. 1987;5:1041\u20139.","journal-title":"J Clin Oncol"},{"key":"324_CR52","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/mpo.10251","volume":"40","author":"C Sandoval","year":"2003","unstructured":"Sandoval C, Swift M. Hodgkin disease in ataxia-telangiectasia patients with poor outcomes. Med Pediatr Oncol. 2003;40:162\u20136.","journal-title":"Med Pediatr Oncol"},{"key":"324_CR53","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1055\/s-2003-45498","volume":"215","author":"T Niehues","year":"2003","unstructured":"Niehues T, Schellong G, D\u00f6rffel W, Bucsky P, Mann G, K\u00f6rholz D, et al. Immunodeficiency and Hodgkin\u2019s disease: treatment and outcome in the DAL HD78-90 and GPOH HD95 studies. Klin Padiatr. 2003;215:315\u201320.","journal-title":"Klin Padiatr"},{"key":"324_CR54","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1002\/pbc.25621","volume":"62","author":"MT Meister","year":"2015","unstructured":"Meister MT, Voss S, Schwabe D. Treatment of EBV-associated nodular sclerosing Hodgkin lymphoma in a patient with ataxia telangiectasia with brentuximab vedotin and reduced COPP plus rituximab. Pediatr Blood Cancer. 2015;62:2018\u201320.","journal-title":"Pediatr Blood Cancer"},{"key":"324_CR55","doi-asserted-by":"crossref","first-page":"e100324","DOI":"10.1371\/journal.pone.0100324","volume":"9","author":"SS Duraisingham","year":"2014","unstructured":"Duraisingham SS, Buckland M, Dempster J, Lorenzo L, Grigoriadou S, Longhurst HJ. Primary vs. secondary antibody deficiency: clinical features and infection outcomes of immunoglobulin replacement. PLoS One. 2014;9:e100324.","journal-title":"PLoS One"},{"key":"324_CR56","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1365-2141.2009.07669.x","volume":"145","author":"H Chapel","year":"2009","unstructured":"Chapel H, Cunningham-Rundles C. Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions. Br J Haematol. 2009;145:709\u201327.","journal-title":"Br J Haematol"},{"key":"324_CR57","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/cup.12230","volume":"40","author":"M Wobser","year":"2013","unstructured":"Wobser M, Kerstan A, Kneitz H, Goebeler M, Kunzmann V, Rosenwald A, et al. Primary cutaneous marginal zone lymphoma with sequential development of nodal marginal zone lymphoma in a patient with selective immunoglobulin A deficiency. J Cutan Pathol. 2013;40:1035\u201341.","journal-title":"J Cutan Pathol"},{"key":"324_CR58","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/00000478-199804000-00017","volume":"22","author":"MM Ott","year":"1998","unstructured":"Ott MM, Ott G, Klinker H, Trunk MJ, Katzenberger T, M\u00fcller-Hermelink HK. Abdominal T-cell non-Hodgkin\u2019s lymphoma of the gamma\/delta type in a patient with selective immunoglobulin A deficiency. Am J Surg Pathol. 1998;22:500\u20136.","journal-title":"Am J Surg Pathol"},{"key":"324_CR59","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/pbc.25856","volume":"63","author":"Y Chen","year":"2016","unstructured":"Chen Y, Jin M, Zhao W, Li S, Wang X, Cai S, et al. DICER1-negative pleuropulmonary blastoma in a patient with selective IgA deficiency. Pediatr Blood Cancer. 2016;63:757\u20138.","journal-title":"Pediatr Blood Cancer"},{"key":"324_CR60","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1007\/s10875-014-0110-8","volume":"34","author":"S Ghosh","year":"2014","unstructured":"Ghosh S, Bienemann K, Boztug K, Borkhardt A. Interleukin-2-inducible T-cell kinase (ITK) deficiency\u2014clinical and molecular aspects. J Clin Immunol. 2014;34:892\u20139.","journal-title":"J Clin Immunol"},{"key":"324_CR61","first-page":"741","volume":"17","author":"TG Gross","year":"1996","unstructured":"Gross TG, Filipovich AH, Conley ME, Pracher E, Schmiegelow K, Verdirame JD, et al. Cure of X-linked lymphoproliferative disease (XLP) with allogeneic hematopoietic stem cell transplantation (HSCT): report from the XLP registry. Bone Marrow Transpl. 1996;17:741\u20134.","journal-title":"Bone Marrow Transpl"},{"key":"324_CR62","doi-asserted-by":"crossref","first-page":"673","DOI":"10.5732\/cjc.012.10238","volume":"32","author":"J Zhu","year":"2013","unstructured":"Zhu J, Zhang Y, Zhen ZJ, Chen Y, Wang J, Cai RQ, et al. Lymphoma and cerebral vasculitis in association with X-linked lymphoproliferative disease. Chin J Cancer. 2013;32:673.","journal-title":"Chin J Cancer"},{"key":"324_CR63","doi-asserted-by":"crossref","unstructured":"Booth C, Gilmour KC, Veys P, Gennery AR, Slatter MA, Chapel H, Heath PT, Steward CG, Smith O, O\u2019Meara A, Kerrigan H, Mahlaoui N, Cavazzana-Calvo M, Fischer A, Moshous D, Blanche S, Pachlopnik Schmid J, Latour S, de Saint-Basile G, Albert M, Notheis G, Rieber N, Strahm B, Ritterbusch H, Lankester A, Hartwig NG, Meyts I, Plebani A, Soresina A, Finocchi A, Pignata C, Cirillo E, Bonanomi S, Peters C, Kalwak K, Pasic S, Sedlacek P, Jazbec J, Kanegane H, Nichols KE, Hanson IC, Kapoor N, Haddad E, Cowan M, Choo S, Smart J, Arkwright PD, Gaspar HB. X-linked lymphoproliferative disease due to SAP\/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease. Blood. 2011;117:53\u201362.","DOI":"10.1182\/blood-2010-06-284935"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-016-0324-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-016-0324-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-016-0324-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T19:21:08Z","timestamp":1600975268000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-016-0324-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,4]]},"references-count":63,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["324"],"URL":"https:\/\/doi.org\/10.1007\/s10875-016-0324-z","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,4]]}}}